Skip to main content
In C3G, help them go forward with FABHALTA. The first and only FDA-approved oral treatment for adults with C3G, to reduce proteinuria.

See how FABHALTA works

Explore the results from the APPEAR-C3G study

Explore the safety profile for FABHALTA

Start your patients today

Definition
MOA, mechanism of action.

Reference
1. Fabhalta. Prescribing information. Novartis Pharmaceuticals Corp.